Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with (44)Sc and (47)Sc for Theranostic Application

This study was performed to synthesize multimodal radiopharmaceutical designed for the diagnosis and treatment of prostate cancer. To achieve this goal, superparamagnetic iron oxide (SPIO) nanoparticles were used as a platform for targeting molecule (PSMA-617) and for complexation of two scandium ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ünak, Perihan, Yasakçı, Volkan, Tutun, Elif, Karatay, K. Buşra, Walczak, Rafał, Wawrowicz, Kamil, Żelechowska-Matysiak, Kinga, Majkowska-Pilip, Agnieszka, Bilewicz, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053001/
https://www.ncbi.nlm.nih.gov/pubmed/36986710
http://dx.doi.org/10.3390/pharmaceutics15030850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053001/
https://www.ncbi.nlm.nih.gov/pubmed/36986710
http://dx.doi.org/10.3390/pharmaceutics15030850

Ejemplares similares